To test whether FSTL1 mediates the effect of disrupted IRF4 expression in skeletal muscles on NASH progression, we performed the transcriptome analysis of liver tissues in Flox, F4MKO, and F4MKO + FSTL1 mice. The gene discussed is IRF4; the disease is metabolic dysfunction-associated steatohepatitis.